m+Medelevator.RU
← Поиск публикаций
Dermatology reports · 2022

A consensus-based approach on the management of patients with both psoriasis and psoriatic arthritis in the dermatological and rheumatological settings in Italy: The ADOI PSO-Amore Project.

СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Cusano Francesco, Sampogna Francesca, Brunasso Vernetti Alexandra Maria Giovanna, Stisi Stefano, Sandri Gilda, Malara Giovanna, Naldi Luigi, Pellegrino Michele, Tripepi Giovanni Luigi, di Luzio Paparatti Umberto, Agnusdei Concetto Paolo, Bonifati Claudio, Celano Antonella, Corazza Valeria, D'Agostino Federica, De Pasquale Rocco, Filippucci Emilio, Foti Rosario, Galdo Giovanna, Gai Fabiana, Ganzetti Giulia, Graceffa Dario, Maccarone Mara, Mazzotta Annamaria, Melchionda Gennaro, Molinaro Francesca, Paoletti Franco, Tonolo Silvia, Vercellone Adriano, Vitetta Rosetta, Massone Cesare, Sebastiani Gian Domenico

Аннотация

Psoriasis is a complex disease often needing a multidisciplinary approach. In particular, the collaboration between dermatologist and rheumatologist is crucial for the management of patients suffering from both psoriasis (PSO) and psoriatic arthritis (PsA). Here we report a series of recommendations from a group of experts, as a result of a Consensus Conference, defining the circumstances in which it is preferable or even mandatory, depending on the available settings, to rely on the opinion of the two specialists, jointly or in a deferred manner. Indications are given on how to organize a 3rd level joint Dermatology- Rheumatology care unit, in connection with 1st and 2nd level clinicians of both specialties, GPs, and other specialists involved in the management of psoriasis. A potential patient journey is suggested, that can be used as a basis for future design and validation of national and/or local diagnostic therapeutic and assistance pathways.

ИП Урсолов Владлен Сергеевич

ИНН 500118482352 · ОГРНИП 314500117700049

Реквизиты и контакты